Gene expression profiling for improved dissection of acute leukemia: A recently identified immature myeloid/T-lymphoid subgroup as an example

Wouters, 2007, Distinct gene expression profiles of acute myeloid/T-lymphoid leukemia with silenced CEBPA and mutations in NOTCH1, Blood, 110, 3706, 10.1182/blood-2007-02-073486 Rosenbauer, 2007, Transcription factors in myeloid development: balancing differentiation with transformation, Nat. Rev. Immunol., 7, 105, 10.1038/nri2024 Nerlov, 2004, C/EBPalpha mutations in acute myeloid leukaemias, Nat. Rev. Cancer, 4, 394, 10.1038/nrc1363 Pabst, 2001, Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-alpha (C/EBPalpha), in acute myeloid leukemia, Nat. Genet., 27, 263, 10.1038/85820 Barjesteh van Waalwijk van Doorn-Khosrovani, 2003, Biallelic mutations in the CEBPA gene and low CEBPA expression levels as prognostic markers in intermediate-risk AML, Hematol. J., 4, 31, 10.1038/sj.thj.6200216 Frohling, 2004, CEBPA mutations in younger adults with acute myeloid leukemia and normal cytogenetics: prognostic relevance and analysis of cooperating mutations, J. Clin. Oncol., 22, 624, 10.1200/JCO.2004.06.060 Bullinger, 2005, Gene expression profiling in acute myeloid leukemia, J. Clin. Oncol., 23, 6296, 10.1200/JCO.2005.05.020 Valk, 2004, Prognostically useful gene-expression profiles in acute myeloid leukemia, N. Engl. J. Med., 350, 1617, 10.1056/NEJMoa040465 Wouters, 2007, Segmental uniparental disomy as a recurrent mechanism for homozygous CEBPA mutations in acute myeloid leukemia, Leukemia, 21, 2382, 10.1038/sj.leu.2404795 Zhang, 2004, Enhancement of hematopoietic stem cell repopulating capacity and self-renewal in the absence of the transcription factor C/EBP alpha, Immunity, 21, 853, 10.1016/j.immuni.2004.11.006 Xie, 2004, Stepwise reprogramming of B cells into macrophages, Cell, 117, 663, 10.1016/S0092-8674(04)00419-2 Fukuchi, 2006, Comprehensive analysis of myeloid lineage conversion using mice expressing an inducible form of C/EBPalpha, Embo. J., 25, 3398, 10.1038/sj.emboj.7601199 Laiosa, 2006, Reprogramming of committed T cell progenitors to macrophages and dendritic cells by C/EBP alpha and PU.1 transcription factors, Immunity, 25, 731, 10.1016/j.immuni.2006.09.011 Keeshan, 2006, Tribbles homolog 2 inactivates C/EBPalpha and causes acute myelogenous leukemia, Cancer Cell, 10, 401, 10.1016/j.ccr.2006.09.012 Leong, 2006, Recent insights into the role of Notch signaling in tumorigenesis, Blood, 107, 2223, 10.1182/blood-2005-08-3329 Weng, 2004, Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia, Science, 306, 269, 10.1126/science.1102160 Palomero, 2006, Activating mutations in NOTCH1 in acute myeloid leukemia and lineage switch leukemias, Leukemia, 20, 1963, 10.1038/sj.leu.2404409 O'Neil, 2007, FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to {gamma}-secretase inhibitors, J. Exp. Med., 204, 1813, 10.1084/jem.20070876 Thompson, 2007, The SCFFBW7 ubiquitin ligase complex as a tumor suppressor in T cell leukemia, J. Exp. Med., 204, 1825, 10.1084/jem.20070872 Pear, 1996, Exclusive development of T cell neoplasms in mice transplanted with bone marrow expressing activated Notch alleles, J. Exp. Med., 183, 2283, 10.1084/jem.183.5.2283 Grimwade, 2002, The T-lineage-affiliated CD2 gene lies within an open chromatin environment in acute promyelocytic leukemia cells, Cancer Res., 62, 4730 Foley, 2001, CD34-positive acute promyelocytic leukemia is associated with leukocytosis, microgranular/hypogranular morphology, expression of CD2 and bcr3 isoform, Am. J. Hematol., 67, 34, 10.1002/ajh.1073 Lin, 2004, Expression of CD2 in acute promyelocytic leukemia correlates with short form of PML-RARalpha transcripts and poorer prognosis, Am. J. Clin. Pathol., 121, 402, 10.1309/XC8P9M8NKQDT38LB van Dongen, 1992, Detection of minimal residual disease in acute leukemia by immunological marker analysis and polymerase chain reaction, Leukemia, 6, 47 Touw, 1991, Acute myeloid leukemias with chromosomal abnormalities involving the 21q22 region identified by their in vitro responsiveness to interleukin-5, Leukemia, 5, 687 Armstrong, 2002, MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia, Nat. Genet., 30, 41, 10.1038/ng765 Chim, 2002, Infrequent hypermethylation of CEBPA promotor in acute myeloid leukaemia, Br. J. Haematol., 119, 988, 10.1046/j.1365-2141.2002.03952.x Tada, 2006, Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer, J. Natl. Cancer Inst., 98, 396, 10.1093/jnci/djj093